Beutel, Goodman & Co’s Sanofi SNY Stock Holding History

Beutel, Goodman & Co’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-500	Closed	-$27K	–	199
2025 Q1	$27K	Buy	+500	New	+$27.1K	﹤0.01%	163

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Beutel, Goodman & Co's SNY Position: Q2 2025 in Review

Beutel, Goodman & Co sold out of Sanofi (SNY) in Q2 2025, closing a stake of 500 shares — an estimated $27K sold.

Beutel, Goodman & Co first reported a position in SNY in Q1 2025 and held it in 1 quarter. The position peaked at $27K in Q1 2025. 729 funds tracked by Wall St. Rank hold SNY as of Q2 2025.

Beutel, Goodman & Co reported no remaining Sanofi position as of Q2 2025 after selling out during the quarter.
Beutel, Goodman & Co sold 500 Sanofi shares in Q2 2025, an estimated $27K.
Beutel, Goodman & Co first reported a position in Sanofi in Q1 2025 and held it in 1 quarter.
Beutel, Goodman & Co's Sanofi position peaked at $27K in Q1 2025.
729 funds tracked by Wall St. Rank held Sanofi as of Q2 2025.

Based on Beutel, Goodman & Co's 13F filing for Q2 2025, filed 13 Aug 2025.